Latest in Cardiology from ACC.org

• TARTAN-HF: NT-proBNP Screening Identifies Undiagnosed HF Among Patients With Diabetes
  A heart failure (HF) screening strategy focused on NT-proBNP identified a large proportion of patients with diabetes who had previously unrecognized but symptomatic HF, according to research published Aug. 19 in JACC.
• Beyond BMI: Body Composition Patterns Emerge in HF
  Study participants with heart failure (HF), compared with controls, had had more visceral adipose tissue (VAT), more adverse muscle changes and weaker grip strength, according to research published Aug. 6 in JACC: Heart Failure.
• Vutrisiran Associated With Favorable Changes in Cardiac Parameters, Amyloid Burden
  In patients with transthyretin amyloid cardiomyopathy (ATTR-CM), treatment with vutrisiran is associated with favorable changes in cardiovascular magnetic resonance (CMR) parameters related to cardiac structure, function and amyloid burden, according to a retrospective post hoc analysis of the HELIOS-B trial published Aug. 12 in JAMA Cardiology.
• State-of-the-Art Review Provides Practical Guidance on Treating Athletes With Arrhythmias
  A recent State-of-the-Art Review published in JACC: Clinical Electrophysiology introduces "sports electrophysiology" as an emerging area within sports cardiology and offers practical guidance for electrophysiologists and cardiovascular clinicians caring for athletic patients with arrhythmias.
• Gestational Diabetes Points to Broader Postpartum CKM Risk
  Gestational diabetes is associated with significantly increased risks of postpartum cardiovascular, kidney and metabolic (CKM) disorders, according to a retrospective cohort study published Aug. 12 in JAMA Network Open.